Ethinylestradiol/drospirenone/folic acid

Drug Profile

Ethinylestradiol/drospirenone/folic acid

Alternative Names: BAY98-7071; Beyaz; EE20/DRSP/L-5MTHF; ethinylestradiol/drospirenone/methyltetrahydrofolate; Safyral; Yasmin Plus; Yaz Flex Plus; Yaz Plus

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer
  • Class Alkylated estrogenic steroids; Androstenes; Antiandrogens; Estradiol congeners; Estrenes; Folic-acids; Hormonal contraceptives; Norpregnatrienes; Oral contraceptives; Progesterone congeners; Vitamins
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris; Pregnancy; Premenstrual dysphoric disorder

Most Recent Events

  • 20 Jul 2015 No recent reports on development identified - Preregistration for Pregnancy (Prevention) in Europe (PO)
  • 01 Feb 2015 Bayer completes a phase III trial in Contraception in Mexico (NCT01902264)
  • 15 Aug 2013 Phase-III clinical trials in Contraception/Pregnancy (Prevention) in Mexico (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top